Plain-English translation of NCT07354009 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study compares two surgical approaches for people who have both cataracts and open-angle glaucoma. Everyone in the trial will have cataract surgery, but some participants will also receive an iStent — a tiny implant designed to help fluid drain from the eye and reduce pressure. Doctors want to see if adding this small device helps control glaucoma better than cataract surgery alone.
Open-angle glaucoma causes vision loss by building up pressure inside the eye. Many patients need cataract surgery anyway, so researchers are testing whether combining it with this tiny drain implant could be a more effective way to treat both conditions at the same time.
You likely qualify if…
You likely don't qualify if…
You will undergo cataract surgery — either with the tiny iStent implant added or without it. You'll be randomly assigned to one of these two groups. After surgery, you'll return for check-ups at 1 day, 1 week, 1 month, 3 months, 6 months, and 12 months so doctors can measure your eye pressure and see how well the treatment is working. The entire study lasts about one year.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
China
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Enrollment target
~60 participants
Started
October 2025
Primary completion
October 2026
Age range
18 Years – 90 Years
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Kaijun wang, MD
Eye Center, the 2nd Affiliated Hospital, Medical College of Zhejiang Universit
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.